ZCCHC4 and neoplasm: Nineteen genes (44%) demonstrated loss or promoter silencing of the wildtype allele in at least one tumour, with six genes (SLC12A4, LOXL2, ZCCHC4, LLGL2, MIPOL1, SCYL3) demonstrating this in multiple samples (Fig. 1).